Cerebra Integrated Technologies Intrinsic Value
Cerebra Integrated Technologies (CEREBRAINT) median intrinsic value is ₹4.85 from 3 valuation models (range ₹1–₹8), vs current price ₹3.11 — +55.9% upside (Trading Below Calculated Value), margin of safety 35.9%. Analyse CEREBRAINT FII DII holdings to track promoter, FII and institutional holdings.
CEREBRAINT Valuation Methods Summary — DCF, Graham Number & P/E
Cerebra Integrated Technologies intrinsic value across 3 models vs current price ₹3.11 — upside/downside and value range per method. For current market price and key ratios, visit CEREBRAINT share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹7.77 | ₹6.99 - ₹8.55 | +149.8% | Book Value/Share: ₹8.30, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹0.93 | ₹0.84 - ₹1.02 | -70.1% | Revenue/Share: ₹0.36, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹4.85 | ₹3.88 - ₹5.82 | +55.9% | CF Growth: 15.0%, Discount: 15% |
CEREBRAINT Intrinsic Value vs Market Price — All Valuation Models
Cerebra Integrated Technologies fair value range ₹1–₹8 vs current market price ₹3.11 across 3 valuation models. Read CEREBRAINT dividend payout details for the complete payout history and dividend yield track record.
CEREBRAINT Intrinsic Value Analysis — Undervalued or Overvalued?
Cerebra Integrated Technologies median intrinsic value ₹4.85, current price ₹3.11 — Trading Below Calculated Value by 55.9%, margin of safety 35.9%.
What is the intrinsic value of CEREBRAINT?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Cerebra Integrated Technologies (CEREBRAINT) is ₹4.85 (median value). With the current market price of ₹3.11, this represents a +55.9% variance from our estimated fair value.
The valuation range spans from ₹0.93 to ₹7.77, indicating ₹0.93 - ₹7.77.
Is CEREBRAINT undervalued or overvalued?
Based on our multi-method analysis, Cerebra Integrated Technologies (CEREBRAINT) appears to be trading below calculated value by approximately 55.9%.
CEREBRAINT Financial Health — Key Ratios vs Industry Benchmarks
Cerebra Integrated Technologies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | -133.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -2912.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.02x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
CEREBRAINT Cash Flow Quality — Operating & Free Cash Flow
Cerebra Integrated Technologies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-2 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-17 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-5 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |